Gentian Diagnostics ASA

Report Publication Announcement • May 9, 2019

First Quarter Financial Report

First Quarter Financial Report

Moss, 9.5.2019

Gentian Diagnostics AS announces its results for the first quarter of 2018. The highlights include:

• Good start to the new fiscal year with sales revenues of MNOK 10.6 for the quarter.

• Record sales achieved for fCAL®turbo, our innovative biomarker for the diagnosis of inflammatory bowel disease.

• New scientific study results confirm GCAL as a promising biomarker for the diagnosis of bacterial infections.

Please find the report and results presentation enclosed. The documents will also be made available on www.gentian.no.

For further information, please contact:

Hilja Ibert

CEO, Gentian Diagnostics

E-mail: hilja.ibert@gentian.no

Cell Phone: +47 919 05 242

Njaal Kind

CFO, Gentian Diagnostics

E-mail: njaal.kind@gentian.no

Cell Phone. +47 919 06 525